These studies are intended to provide a good sense for the breadth and depth of Indigotism's experience, and how that might prove of value to your business.

Indigotism enlisted in successful flotation of ReNeuron Group plc onto London's Alternative Investment Market (AIM).

This Merlin-backed UK cell therapy pioneer needed to raise funds to take its leading candidate for treatment of stroke damage, through clinical trials.

With the existing COO Michael Hunt stepping up to lead the company, Indigotism were engaged to provide a 'shot in the arm' leading up to the AIM listing, working with PriceWaterhouseCoopers to complete the audit, due diligence and short / long form reporting to tight timescales demanded by tough market conditions.

In conjunction with this, Indigotism ran internal projects delivering valuable grant income, identifying tax savings, and renegotiating supplier contracts, before recruiting an experienced project finance manager into the ReNeuron team.

An extract from the full press release in shown below:

ReNeuron (RENE.L)

LONDON, Aug 5 (Reuters) - British stem-cell company ReNeuron Group Plc successfully completed its return to the London stock market on Friday after raising 9.5 million pounds ($16.90 million) in a share offering in the United States and Britain.

The group, based in Guildford, will use the funds to pay for clinical trials of an experimental stem-cell treatment for strokes.

ReNeuron became Europe's first stem-cell company to float in 2000, but was taken private in 2003 after a series of drug disappointments and the bursting of the technology bubble hammered its share price.

It was bought by biotech investor Chris Evans's Merlin Biosciences for just 3.6 million pounds two years ago. Now its return to London's junior Alternative Investment Market (AIM) will give it a market value of 23.4 million pounds.

Turning around a Telecoms Equipment Supplier

This subsidiary of a European listed telecommunication equipment manufacturer, was consuming significant volumes of cash without showing any returns.

The brief was to establish root cause of the problem, resolve the immediate commercial and financial issues and present back to the parent board a long term success plan.

As a result of this plan, some significantly unprofitable product areas and functions were identified, and the business was turned into profit.

Subsequently, while managing a sale process as part of an exit plan for the parent, a cash buyer was found to secure a long term future for the operation.

Growing a $4bn NASDAQ corporation from Technology Spin-Out

Following acquisition of this Cambridge spin-out by a US corporation, the brief was to establish a secure European support infrastructure for rapid growth of both technology and markets.

Exceeding all targets, the spin out grew rapidly to involve over 200 staff both in Europe and the US and became the sole business of the parent.

During this period the remit extended to include building relations with investors, establishing JV relationships in new markets,  implementing Oracle business software and managing the IT infrastructure, recruiting all talent needs, and delivering the facilities solutions to meet aggressive European growth plans.

Improving Profits and Cash-flow for a Mobile Operator pre-IPO

In the post-dotcom-boom environment, establishing sensible, profitable business models became an urgent priority as owners sought to manage their ability to service debt.

The challenge was to improve the key performance indicators for the business. This meant growing the network while reducing operating and capital costs dramatically. To achieve this, a 'bang for your buck' approach was introduced, with sound analysis of each area of the business and investment opportunity to eliminate waste.

As well as running programmes such as operations process improvement, financial training for non-financial managers, and introducing economic value-added concepts , a permanent professional team was recruited from scratch to run strong analytical disciplines alongside the engineering teams. The business was soon able to overtake it's nearest competitor.

Raising £4M for a life sciences technology company.

With established provenance in its field, this technology development hothouse was looking to go direct to end customers with its next products, rather than out-licence them.

The brief was initially to produce and present a business plan to venture capital sources. This was extended to providing an in-house CFO resource, revising the business strategy, pitching the logic to banks, business angels, VC/VCT's and both City and European institutions.

As a result, despite tough market conditions, funds were successfully raised firstly to cover extended product development timescales, and subsequently to enable the launch of direct products - the business achieving its goals including the first $1m+ order.

Delivering a VC-fundable proposition for E-Commerce start-up

After initial success with its first customers, the founders of this internet company needed to recruit talent to build a sales organisation. Revenues lacked the critical mass to fund this, and with the banks cautious given absence of physical assets, there was a  need for outside capital.

The brief was to develop a sound case for scaling up the business to take advantage of its technology, which enables media customers to charge anytime, anywhere for access to internet content.

By successfully demonstrating the technology's unique qualities and market size/growth rates, an offer of funding was secured for the business founders.

For more information, contact Indigotism at

[ Home ] [ Up ]

Send mail to with questions or comments about this web site.
Copyright © 2005 Indigotism
Last modified: 09/12/08